5flc › Citations

Architecture of human mTOR complex 1.

Aylett CH, Sauer E, Imseng S, Boehringer D, Hall MN, Ban N, Maier T
Science 351 48-52 (2016)
Cited: 197 times
EuropePMC logo PMID: 26678875

Abstract

Target of rapamycin (TOR), a conserved protein kinase and central controller of cell growth, functions in two structurally and functionally distinct complexes: TORC1 and TORC2. Dysregulation of mammalian TOR (mTOR) signaling is implicated in pathologies that include diabetes, cancer, and neurodegeneration. We resolved the architecture of human mTORC1 (mTOR with subunits Raptor and mLST8) bound to FK506 binding protein (FKBP)-rapamycin, by combining cryo-electron microscopy at 5.9 angstrom resolution with crystallographic studies of Chaetomium thermophilum Raptor at 4.3 angstrom resolution. The structure explains how FKBP-rapamycin and architectural elements of mTORC1 limit access to the recessed active site. Consistent with a role in substrate recognition and delivery, the conserved amino-terminal domain of Raptor is juxtaposed to the kinase active site.

Reviews - 5flc mentioned but not cited (6)

  1. mTOR Signaling in Growth, Metabolism, and Disease. Saxton RA, Sabatini DM. Cell 168 960-976 (2017)
  2. mTOR at the nexus of nutrition, growth, ageing and disease. Liu GY, Sabatini DM. Nat Rev Mol Cell Biol 21 183-203 (2020)
  3. Regulation of Cellular Metabolism through Phase Separation of Enzymes. Prouteau M, Loewith R. Biomolecules 8 E160 (2018)
  4. MultiBac: from protein complex structures to synthetic viral nanosystems. Pelosse M, Crocker H, Gorda B, Lemaire P, Rauch J, Berger I. BMC Biol 15 99 (2017)
  5. Next-generation electron microscopy in autophagy research. Hurley JH, Nogales E. Curr Opin Struct Biol 41 211-216 (2016)
  6. Substrate-selective small-molecule modulators of enzymes: Mechanisms and opportunities. Lin H. Curr Opin Chem Biol 72 102231 (2023)

Articles - 5flc mentioned but not cited (11)

  1. TORC1 organized in inhibited domains (TOROIDs) regulate TORC1 activity. Prouteau M, Desfosses A, Sieben C, Bourgoint C, Lydia Mozaffari N, Demurtas D, Mitra AK, Guichard P, Manley S, Loewith R. Nature 550 265-269 (2017)
  2. The Dimeric Architecture of Checkpoint Kinases Mec1ATR and Tel1ATM Reveal a Common Structural Organization. Sawicka M, Wanrooij PH, Darbari VC, Tannous E, Hailemariam S, Bose D, Makarova AV, Burgers PM, Zhang X. J Biol Chem 291 13436-13447 (2016)
  3. Cryo-EM structure of the SAGA and NuA4 coactivator subunit Tra1 at 3.7 angstrom resolution. Díaz-Santín LM, Lukoyanova N, Aciyan E, Cheung AC. Elife 6 e28384 (2017)
  4. A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers. Lawal B, Lo WC, Mokgautsi N, Sumitra MR, Khedkar H, Wu AT, Huang HS. Am J Cancer Res 11 2590-2617 (2021)
  5. Discovery of an Unnatural DNA Modification Derived from a Natural Secondary Metabolite. Wang T, Kohli RM. Cell Chem Biol 28 97-104.e4 (2021)
  6. Selective human inhibitors of ATR and ATM render Leishmania major promastigotes sensitive to oxidative damage. da Silva RB, Machado CR, Rodrigues ARA, Pedrosa AL. PLoS One 13 e0205033 (2018)
  7. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling. Wu ATH, Huang HS, Huang HS, Wen YT, Lawal B, Mokgautsi N, Huynh TT, Hsiao M, Wei L. Cells 10 2391 (2021)
  8. Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule. Lawal B, Wu ATH, Huang HS. Front Immunol 13 872470 (2022)
  9. CDAE: A Cascade of Denoising Autoencoders for Noise Reduction in the Clustering of Single-Particle Cryo-EM Images. Lei H, Yang Y. Front Genet 11 627746 (2020)
  10. Rapamycin Exacerbates Staphylococcus aureus Pneumonia by Inhibiting mTOR-RPS6 in Macrophages. Yu FY, Zheng K, Wu YF, Gao SW, Weng QY, Zhu C, Wu YP, Li M, Qin ZN, Lou JF, Chen ZH, Ying SM, Shen HH, Li W. J Inflamm Res 16 5715-5728 (2023)
  11. SUMO modifies GβL and mediates mTOR signaling. Park SLL, Ramírez-Jarquín UN, Shahani N, Rivera O, Sharma M, Joshi PS, Hansalia A, Dagar S, McManus FP, Thibault P, Subramaniam S. J Biol Chem 300 105778 (2024)


Reviews citing this publication (80)

  1. mTOR as a central hub of nutrient signalling and cell growth. Kim J, Guan KL. Nat Cell Biol 21 63-71 (2019)
  2. Targeting mTOR for cancer therapy. Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y. J Hematol Oncol 12 71 (2019)
  3. The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging. Kennedy BK, Lamming DW. Cell Metab 23 990-1003 (2016)
  4. mTORC1 and mTORC2 in cancer and the tumor microenvironment. Kim LC, Cook RS, Chen J. Oncogene 36 2191-2201 (2017)
  5. Molecular neurobiology of mTOR. Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J. Neuroscience 341 112-153 (2017)
  6. Regulation and metabolic functions of mTORC1 and mTORC2. Szwed A, Kim E, Jacinto E. Physiol Rev 101 1371-1426 (2021)
  7. Unravelling biological macromolecules with cryo-electron microscopy. Fernandez-Leiro R, Scheres SH. Nature 537 339-346 (2016)
  8. Nutrient regulation of mTORC1 at a glance. Condon KJ, Sabatini DM. J Cell Sci 132 jcs222570 (2019)
  9. mTOR Pathways in Cancer and Autophagy. Paquette M, El-Houjeiri L, Pause A. Cancers (Basel) 10 E18 (2018)
  10. TORC2 Structure and Function. Gaubitz C, Prouteau M, Kusmider B, Loewith R. Trends Biochem Sci 41 532-545 (2016)
  11. mTOR inhibitors in cancer therapy. Xie J, Wang X, Proud CG. F1000Res 5 F1000 Faculty Rev-2078 (2016)
  12. Amino acid-dependent control of mTORC1 signaling: a variety of regulatory modes. Takahara T, Amemiya Y, Sugiyama R, Maki M, Shibata H. J Biomed Sci 27 87 (2020)
  13. TOR signaling in plants: conservation and innovation. Shi L, Wu Y, Sheen J. Development 145 dev160887 (2018)
  14. mTOR: A Cellular Regulator Interface in Health and Disease. Boutouja F, Stiehm CM, Platta HW. Cells 8 E18 (2019)
  15. Advances in Autophagy Regulatory Mechanisms. Gallagher LE, Williamson LE, Chan EY. Cells 5 E24 (2016)
  16. Evolutionary Conservation of the Components in the TOR Signaling Pathways. Tatebe H, Shiozaki K. Biomolecules 7 E77 (2017)
  17. Integration of nutrient, energy, light, and hormone signalling via TOR in plants. Wu Y, Shi L, Li L, Fu L, Liu Y, Xiong Y, Sheen J. J Exp Bot 70 2227-2238 (2019)
  18. Structural basis of homologous recombination. Sun Y, McCorvie TJ, Yates LA, Zhang X. Cell Mol Life Sci 77 3-18 (2020)
  19. An overview of rapamycin: from discovery to future perspectives. Yoo YJ, Kim H, Park SR, Yoon YJ. J Ind Microbiol Biotechnol 44 537-553 (2017)
  20. Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity. Faes S, Demartines N, Dormond O. Oxid Med Cell Longev 2017 1726078 (2017)
  21. Regulation of mTORC1 by Upstream Stimuli. Melick CH, Jewell JL. Genes (Basel) 11 E989 (2020)
  22. Cryo-EM: beyond the microscope. Earl LA, Falconieri V, Milne JL, Subramaniam S. Curr Opin Struct Biol 46 71-78 (2017)
  23. The TORC2-Dependent Signaling Network in the Yeast Saccharomyces cerevisiae. Roelants FM, Leskoske KL, Martinez Marshall MN, Locke MN, Thorner J. Biomolecules 7 E66 (2017)
  24. The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond. Lee PL, Jung SM, Guertin DA. Trends Endocrinol Metab 28 319-339 (2017)
  25. The Architecture of the Rag GTPase Signaling Network. Nicastro R, Sardu A, Panchaud N, De Virgilio C. Biomolecules 7 E48 (2017)
  26. Recent advances and limitations of mTOR inhibitors in the treatment of cancer. Ali ES, Mitra K, Akter S, Ramproshad S, Mondal B, Khan IN, Islam MT, Sharifi-Rad J, Calina D, Cho WC. Cancer Cell Int 22 284 (2022)
  27. Lysosomal Regulation of mTORC1 by Amino Acids in Mammalian Cells. Yao Y, Jones E, Inoki K. Biomolecules 7 E51 (2017)
  28. Weighing In on mTOR Complex 2 Signaling: The Expanding Role in Cell Metabolism. Luo Y, Xu W, Li G, Cui W. Oxid Med Cell Longev 2018 7838647 (2018)
  29. TORC1-Dependent Phosphorylation Targets in Fission Yeast. Otsubo Y, Nakashima A, Yamamoto M, Yamashita A. Biomolecules 7 E50 (2017)
  30. Role of mTORC1 Controlling Proteostasis after Brain Ischemia. Perez-Alvarez MJ, Villa Gonzalez M, Benito-Cuesta I, Wandosell FG. Front Neurosci 12 60 (2018)
  31. Target of Rapamycin kinase: central regulatory hub for plant growth and metabolism. Ryabova LA, Robaglia C, Meyer C. J Exp Bot 70 2211-2216 (2019)
  32. The TOR Signaling Network in the Model Unicellular Green Alga Chlamydomonas reinhardtii. Pérez-Pérez ME, Couso I, Crespo JL. Biomolecules 7 E54 (2017)
  33. Inhibiting 4EBP1 in Glioblastoma. Fan QW, Nicolaides TP, Weiss WA. Clin Cancer Res 24 14-21 (2018)
  34. The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC). Feliciano DM. Front Neuroanat 14 39 (2020)
  35. Evolution of TOR-SnRK dynamics in green plants and its integration with phytohormone signaling networks. Jamsheer K M, Jindal S, Laxmi A. J Exp Bot 70 2239-2259 (2019)
  36. The LRRK2 signalling system. Price A, Manzoni C, Cookson MR, Lewis PA. Cell Tissue Res 373 39-50 (2018)
  37. Resistance Exercise-Induced Hypertrophy: A Potential Role for Rapamycin-Insensitive mTOR. Ogasawara R, Jensen TE, Goodman CA, Hornberger TA. Exerc Sport Sci Rev 47 188-194 (2019)
  38. Targeting the biology of aging with mTOR inhibitors. Mannick JB, Lamming DW. Nat Aging 3 642-660 (2023)
  39. The Importance of TOR Kinase in Plant Development. McCready K, Spencer V, Kim M. Front Plant Sci 11 16 (2020)
  40. Dysregulation of mRNA translation and energy metabolism in cancer. Leibovitch M, Topisirovic I. Adv Biol Regul 67 30-39 (2018)
  41. Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases. Samidurai A, Kukreja RC, Das A. Oxid Med Cell Longev 2018 6141902 (2018)
  42. Structural Insights into TOR Signaling. Tafur L, Kefauver J, Loewith R. Genes (Basel) 11 E885 (2020)
  43. "mTOR Signaling Pathway": A Potential Target of Curcumin in the Treatment of Spinal Cord Injury. Lin J, Huo X, Liu X. Biomed Res Int 2017 1634801 (2017)
  44. The Translational Regulation in mTOR Pathway. Yang M, Lu Y, Piao W, Jin H. Biomolecules 12 802 (2022)
  45. Target of Rapamycin in Control of Autophagy: Puppet Master and Signal Integrator. Mugume Y, Kazibwe Z, Bassham DC. Int J Mol Sci 21 E8259 (2020)
  46. Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers. Lineham E, Spencer J, Morley SJ. Future Med Chem 9 1539-1555 (2017)
  47. Molecular Mechanisms Controlled by mTOR in Male Reproductive System. Moreira BP, Oliveira PF, Alves MG. Int J Mol Sci 20 E1633 (2019)
  48. Nuclear Functions of TOR: Impact on Transcription and the Epigenome. Laribee RN, Weisman R. Genes (Basel) 11 E641 (2020)
  49. The magic 'hammer' of TOR: the multiple faces of a single pathway in the metabolic regulation of plant growth and development. Caldana C, Martins MCM, Mubeen U, Urrea-Castellanos R. J Exp Bot 70 2217-2225 (2019)
  50. Cryo-electron Microscopy Analysis of Structurally Heterogeneous Macromolecular Complexes. Jonić S. Comput Struct Biotechnol J 14 385-390 (2016)
  51. Nitrogen-dependent coordination of cell cycle, quiescence and TAG accumulation in Chlamydomonas. Takeuchi T, Benning C. Biotechnol Biofuels 12 292 (2019)
  52. The role of metabolic ecosystem in cancer progression - metabolic plasticity and mTOR hyperactivity in tumor tissues. Sebestyén A, Dankó T, Sztankovics D, Moldvai D, Raffay R, Cervi C, Krencz I, Zsiros V, Jeney A, Petővári G. Cancer Metastasis Rev 40 989-1033 (2021)
  53. Beyond the known functions of the CCR4-NOT complex in gene expression regulatory mechanisms: New structural insights to unravel CCR4-NOT mRNA processing machinery. Ukleja M, Valpuesta JM, Dziembowski A, Cuellar J. Bioessays 38 1048-1058 (2016)
  54. Nutrient Signaling and Lysosome Positioning Crosstalk Through a Multifunctional Protein, Folliculin. de Martín Garrido N, Aylett CHS. Front Cell Dev Biol 8 108 (2020)
  55. The Plant Target of Rapamycin: A Conduc TOR of Nutrition and Metabolism in Photosynthetic Organisms. Ingargiola C, Turqueto Duarte G, Robaglia C, Leprince AS, Meyer C. Genes (Basel) 11 E1285 (2020)
  56. The role of RICTOR amplification in targeted therapy and drug resistance. Zhao D, Jiang M, Zhang X, Hou H. Mol Med 26 20 (2020)
  57. Animal source foods, rich in essential amino acids, are important for linear growth and development of young children in low- and middle-income countries. Parikh P, Semba R, Manary M, Swaminathan S, Udomkesmalee E, Bos R, Poh BK, Rojroongwasinkul N, Geurts J, Sekartini R, Nga TT. Matern Child Nutr 18 e13264 (2022)
  58. Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics. Bhaoighill MN, Dunlop EA. Cancer Drug Resist 2 1069-1085 (2019)
  59. Eosinophilic Vacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss. Kapur P, Gao M, Zhong H, Rakheja D, Cai Q, Pedrosa I, Margulis V, Xu L, Kinch L, Brugarolas J. Adv Anat Pathol 28 251-257 (2021)
  60. Sensors for the mTORC1 pathway regulated by amino acids. Li XZ, Yan XH. J Zhejiang Univ Sci B 20 699-712 (2019)
  61. Targeting the mTOR pathway in breast cancer. Liu J, Li HQ, Zhou FX, Yu JW, Sun L, Han ZH. Tumour Biol 39 1010428317710825 (2017)
  62. Cryo-EM insight into the structure of MTOR complex 1 and its interactions with Rheb and substrates. Chao LH, Avruch J. F1000Res 8 F1000 Faculty Rev-14 (2019)
  63. Transcriptional Regulation of NK Cell Development by mTOR Complexes. Yang C, Malarkannan S. Front Cell Dev Biol 8 566090 (2020)
  64. mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro. Ayuk SM, Abrahamse H. Cells 8 E431 (2019)
  65. mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model. Polchi A, Magini A, Meo DD, Tancini B, Emiliani C. Int J Mol Sci 19 E1474 (2018)
  66. Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia. Sirago G, Picca A, Calvani R, Coelho-Júnior HJ, Marzetti E. Int J Mol Sci 23 13823 (2022)
  67. Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain. Cho C, Michailidis V, Martin LJ. Neurobiol Pain 4 27-34 (2018)
  68. Synthesis and biological evaluation of rapamycin-derived, next generation small molecules. Guduru SKR, Arya P. Medchemcomm 9 27-43 (2018)
  69. mTOR Signaling in the Inner Ear as Potential Target to Treat Hearing Loss. Cortada M, Levano S, Bodmer D. Int J Mol Sci 22 6368 (2021)
  70. mTORC1 Crosstalk With Stress Granules in Aging and Age-Related Diseases. Cadena Sandoval M, Heberle AM, Rehbein U, Barile C, Ramos Pittol JM, Thedieck K. Front Aging 2 761333 (2021)
  71. Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma. Riquelme I, Pérez-Moreno P, Mora-Lagos B, Ili C, Brebi P, Roa JC. Int J Mol Sci 24 6294 (2023)
  72. Pathological Consequences of Hepatic mTORC1 Dysregulation. Cho CS, Kowalsky AH, Lee JH. Genes (Basel) 11 E896 (2020)
  73. Rapamycin, the only drug that has been consistently demonstrated to increase mammalian longevity. An update. Sharp ZD, Strong R. Exp Gerontol 176 112166 (2023)
  74. The metaphorical swiss army knife: The multitude and diverse roles of HEAT domains in eukaryotic translation initiation. Friedrich D, Marintchev A, Arthanari H. Nucleic Acids Res 50 5424-5442 (2022)
  75. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Goul C, Peruzzo R, Zoncu R. Nat Rev Mol Cell Biol 24 857-875 (2023)
  76. Regulation of mTOR by phosphatidic acid. Frias MA, Hatipoglu A, Foster DA. Trends Endocrinol Metab 34 170-180 (2023)
  77. mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity. Mota-Martorell N, Jové M, Pamplona R. Int J Mol Sci 23 8747 (2022)
  78. Eukaryotic response to hypothermia in relation to integrated stress responses. Adjirackor NA, Harvey KE, Harvey SC. Cell Stress Chaperones 25 833-846 (2020)
  79. Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis. Zhang F, Cheng T, Zhang SX. Arthritis Res Ther 25 187 (2023)
  80. TOR Complex 1: Orchestrating Nutrient Signaling and Cell Cycle Progression. Foltman M, Sanchez-Diaz A. Int J Mol Sci 24 15745 (2023)

Articles citing this publication (100)

  1. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Yang H, Jiang X, Li B, Yang HJ, Miller M, Yang A, Dhar A, Pavletich NP. Nature 552 368-373 (2017)
  2. Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2. Zhang H, Lin C, Zeng C, Wang Z, Wang H, Lu J, Liu X, Shao Y, Zhao C, Pan J, Xu S, Zhang Y, Xie D, Cai D, Bai X. Ann Rheum Dis 77 1524-1534 (2018)
  3. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Wang B, Jie Z, Joo D, Ordureau A, Liu P, Gan W, Guo J, Zhang J, North BJ, Dai X, Cheng X, Bian X, Zhang L, Harper JW, Sun SC, Wei W. Nature 545 365-369 (2017)
  4. Prevotella copri increases fat accumulation in pigs fed with formula diets. Chen C, Fang S, Wei H, He M, Fu H, Xiong X, Zhou Y, Wu J, Gao J, Yang H, Huang L. Microbiome 9 175 (2021)
  5. Cryo-EM Structure of the Human FLCN-FNIP2-Rag-Ragulator Complex. Shen K, Rogala KB, Chou HT, Huang RK, Yu Z, Sabatini DM. Cell 179 1319-1329.e8 (2019)
  6. Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin. Xu J, Pham CG, Albanese SK, Dong Y, Oyama T, Lee CH, Rodrik-Outmezguine V, Yao Z, Han S, Chen D, Parton DL, Chodera JD, Rosen N, Cheng EH, Hsieh JJ. J Clin Invest 126 3526-3540 (2016)
  7. Structures of the cyanobacterial circadian oscillator frozen in a fully assembled state. Snijder J, Schuller JM, Wiegard A, Lössl P, Schmelling N, Axmann IM, Plitzko JM, Förster F, Heck AJ. Science 355 1181-1184 (2017)
  8. Cryo-EM structure of human mTOR complex 2. Chen X, Liu M, Tian Y, Li J, Qi Y, Zhao D, Wu Z, Huang M, Wong CCL, Wang HW, Wang J, Yang H, Xu Y. Cell Res 28 518-528 (2018)
  9. Poxviruses Evade Cytosolic Sensing through Disruption of an mTORC1-mTORC2 Regulatory Circuit. Meade N, Furey C, Li H, Verma R, Chai Q, Rollins MG, DiGiuseppe S, DiGiuseppe S, Naghavi MH, Walsh D. Cell 174 1143-1157.e17 (2018)
  10. ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer. Harwood FC, Klein Geltink RI, O'Hara BP, Cardone M, Janke L, Finkelstein D, Entin I, Paul L, Houghton PJ, Grosveld GC. Sci Adv 4 eaar3938 (2018)
  11. Structures of closed and open conformations of dimeric human ATM. Baretić D, Pollard HK, Fisher DI, Johnson CM, Santhanam B, Truman CM, Kouba T, Fersht AR, Phillips C, Williams RL. Sci Adv 3 e1700933 (2017)
  12. Tor forms a dimer through an N-terminal helical solenoid with a complex topology. Baretić D, Berndt A, Ohashi Y, Johnson CM, Williams RL. Nat Commun 7 11016 (2016)
  13. Architecture of human Rag GTPase heterodimers and their complex with mTORC1. Anandapadamanaban M, Masson GR, Perisic O, Berndt A, Kaufman J, Johnson CM, Santhanam B, Rogala KB, Sabatini DM, Williams RL. Science 366 203-210 (2019)
  14. Hybrid Structure of the RagA/C-Ragulator mTORC1 Activation Complex. Su MY, Morris KL, Kim DJ, Fu Y, Lawrence R, Stjepanovic G, Zoncu R, Hurley JH. Mol Cell 68 835-846.e3 (2017)
  15. The in vivo ISGylome links ISG15 to metabolic pathways and autophagy upon Listeria monocytogenes infection. Zhang Y, Thery F, Wu NC, Luhmann EK, Dussurget O, Foecke M, Bredow C, Jiménez-Fernández D, Leandro K, Beling A, Knobeloch KP, Impens F, Cossart P, Radoshevich L. Nat Commun 10 5383 (2019)
  16. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation. Hou X, Rooklin D, Fang H, Zhang Y. Sci Rep 6 38186 (2016)
  17. The 3.2-Å resolution structure of human mTORC2. Scaiola A, Mangia F, Imseng S, Boehringer D, Berneiser K, Shimobayashi M, Stuttfeld E, Hall MN, Ban N, Maier T. Sci Adv 6 eabc1251 (2020)
  18. 4.4 Å Resolution Cryo-EM structure of human mTOR Complex 1. Yang H, Wang J, Liu M, Chen X, Huang M, Tan D, Dong MQ, Wong CC, Wang J, Xu Y, Wang HW. Protein Cell 7 878-887 (2016)
  19. Architecture of the human mTORC2 core complex. Stuttfeld E, Aylett CH, Imseng S, Boehringer D, Scaiola A, Sauer E, Hall MN, Maier T, Ban N. Elife 7 e33101 (2018)
  20. Structural and functional analysis of the role of the chaperonin CCT in mTOR complex assembly. Cuéllar J, Ludlam WG, Tensmeyer NC, Aoba T, Dhavale M, Santiago C, Bueno-Carrasco MT, Mann MJ, Plimpton RL, Makaju A, Franklin S, Willardson BM, Valpuesta JM. Nat Commun 10 2865 (2019)
  21. Circular RNA circ-FoxO3 attenuates blood-brain barrier damage by inducing autophagy during ischemia/reperfusion. Yang Z, Huang C, Wen X, Liu W, Huang X, Li Y, Zang J, Weng Z, Lu D, Tsang CK, Li K, Xu A. Mol Ther 30 1275-1287 (2022)
  22. Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies. Tramutola A, Lanzillotta C, Di Domenico F. Expert Rev Neurother 17 33-45 (2017)
  23. 3.9 Å structure of the yeast Mec1-Ddc2 complex, a homolog of human ATR-ATRIP. Wang X, Ran T, Zhang X, Xin J, Zhang Z, Wu T, Wang W, Cai G. Science 358 1206-1209 (2017)
  24. Architecture of the Saccharomyces cerevisiae NuA4/TIP60 complex. Wang X, Ahmad S, Zhang Z, Côté J, Cai G. Nat Commun 9 1147 (2018)
  25. Cryo-EM structure of human ATR-ATRIP complex. Rao Q, Liu M, Tian Y, Wu Z, Hao Y, Song L, Qin Z, Ding C, Wang HW, Wang J, Xu Y. Cell Res 28 143-156 (2018)
  26. Cryo-EM structure of Saccharomyces cerevisiae target of rapamycin complex 2. Karuppasamy M, Kusmider B, Oliveira TM, Gaubitz C, Prouteau M, Loewith R, Schaffitzel C. Nat Commun 8 1729 (2017)
  27. Gtr/Ego-independent TORC1 activation is achieved through a glutamine-sensitive interaction with Pib2 on the vacuolar membrane. Ukai H, Araki Y, Kira S, Oikawa Y, May AI, Noda T. PLoS Genet 14 e1007334 (2018)
  28. mTOR Dysregulation by Vaccinia Virus F17 Controls Multiple Processes with Varying Roles in Infection. Meade N, King M, Munger J, Walsh D. J Virol 93 e00784-19 (2019)
  29. Interaction network of the ribosome assembly machinery from a eukaryotic thermophile. Baßler J, Ahmed YL, Kallas M, Kornprobst M, Calviño FR, Gnädig M, Thoms M, Stier G, Ismail S, Kharde S, Castillo N, Griesel S, Bastuck S, Bradatsch B, Thomson E, Flemming D, Sinning I, Hurt E. Protein Sci 26 327-342 (2017)
  30. Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy. Sathe A, Chalaud G, Oppolzer I, Wong KY, von Busch M, Schmid SC, Tong Z, Retz M, Gschwend JE, Schulz WA, Nawroth R. PLoS One 13 e0190854 (2018)
  31. Architecture of the human PI4KIIIα lipid kinase complex. Lees JA, Zhang Y, Oh MS, Schauder CM, Yu X, Baskin JM, Dobbs K, Notarangelo LD, De Camilli P, Walz T, Reinisch KM. Proc Natl Acad Sci U S A 114 13720-13725 (2017)
  32. Structure of the human dimeric ATM kinase. Lau WC, Li Y, Liu Z, Gao Y, Zhang Q, Huen MS. Cell Cycle 15 1117-1124 (2016)
  33. Structure of the transcription activator target Tra1 within the chromatin modifying complex SAGA. Sharov G, Voltz K, Durand A, Kolesnikova O, Papai G, Myasnikov AG, Dejaegere A, Ben Shem A, Schultz P. Nat Commun 8 1556 (2017)
  34. The Stress-Sensing TORC2 Complex Activates Yeast AGC-Family Protein Kinase Ypk1 at Multiple Novel Sites. Leskoske KL, Roelants FM, Martinez Marshall MN, Hill JM, Thorner J. Genetics 207 179-195 (2017)
  35. Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth In Vivo. Hwang Y, Kim LC, Song W, Edwards DN, Cook RS, Chen J. Cancer Res 79 3178-3184 (2019)
  36. Phosphorus Availability Regulates TORC1 Signaling via LST8 in Chlamydomonas. Couso I, Pérez-Pérez ME, Ford MM, Martínez-Force E, Hicks LM, Umen JG, Crespo JL. Plant Cell 32 69-80 (2020)
  37. Perspective: The Potential Role of Essential Amino Acids and the Mechanistic Target of Rapamycin Complex 1 (mTORC1) Pathway in the Pathogenesis of Child Stunting. Semba RD, Trehan I, Gonzalez-Freire M, Kraemer K, Moaddel R, Ordiz MI, Ferrucci L, Manary MJ. Adv Nutr 7 853-865 (2016)
  38. Structural insights of mTOR complex 1. Yuan HX, Guan KL. Cell Res 26 267-268 (2016)
  39. TBK1 Limits mTORC1 by Promoting Phosphorylation of Raptor Ser877. Antonia RJ, Castillo J, Herring LE, Serafin DS, Liu P, Graves LM, Baldwin AS, Hagan RS. Sci Rep 9 13470 (2019)
  40. Molecular Transducers of Human Skeletal Muscle Remodeling under Different Loading States. Stokes T, Timmons JA, Crossland H, Tripp TR, Murphy K, McGlory C, Mitchell CJ, Oikawa SY, Morton RW, Phillips BE, Baker SK, Atherton PJ, Wahlestedt C, Phillips SM. Cell Rep 32 107980 (2020)
  41. Quantitative Phosphoproteomic and System-Level Analysis of TOR Inhibition Unravel Distinct Organellar Acclimation in Chlamydomonas reinhardtii. Roustan V, Weckwerth W. Front Plant Sci 9 1590 (2018)
  42. Tunneling Nanotubes Mediated microRNA-155 Intercellular Transportation Promotes Bladder Cancer Cells' Invasive and Proliferative Capacity. Lu JJ, Yang WM, Li F, Zhu W, Chen Z. Int J Nanomedicine 14 9731-9743 (2019)
  43. mTORC1 signalling is not essential for the maintenance of muscle mass and function in adult sedentary mice. Ham AS, Chojnowska K, Tintignac LA, Lin S, Schmidt A, Ham DJ, Sinnreich M, Rüegg MA. J Cachexia Sarcopenia Muscle 11 259-273 (2020)
  44. The Rag GTPase Regulates the Dynamic Behavior of TSC Downstream of Both Amino Acid and Growth Factor Restriction. Yang S, Zhang Y, Ting CY, Bettedi L, Kim K, Ghaniam E, Lilly MA. Dev Cell 55 272-288.e5 (2020)
  45. Essential amino acid ingestion alters expression of genes associated with amino acid sensing, transport, and mTORC1 regulation in human skeletal muscle. Graber TG, Borack MS, Reidy PT, Volpi E, Rasmussen BB. Nutr Metab (Lond) 14 35 (2017)
  46. Molecular Architecture of the Essential Yeast Histone Acetyltransferase Complex NuA4 Redefines Its Multimodularity. Setiaputra D, Ahmad S, Dalwadi U, Steunou AL, Lu S, Ross JD, Dong MQ, Côté J, Yip CK. Mol Cell Biol 38 e00570-17 (2018)
  47. cPKCγ-Modulated Sequential Reactivation of mTOR Inhibited Autophagic Flux in Neurons Exposed to Oxygen Glucose Deprivation/Reperfusion. Hua R, Han S, Zhang N, Dai Q, Liu T, Li J. Int J Mol Sci 19 E1380 (2018)
  48. A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. Dela Cruz FS, Diolaiti D, Turk AT, Rainey AR, Ambesi-Impiombato A, Andrews SJ, Mansukhani MM, Nagy PL, Alvarez MJ, Califano A, Forouhar F, Modzelewski B, Mitchell CM, Yamashiro DJ, Marks LJ, Glade Bender JL, Kung AL. Genome Med 8 116 (2016)
  49. Caspase-mediated cleavage of raptor participates in the inactivation of mTORC1 during cell death. Martin R, Desponds C, Eren RO, Quadroni M, Thome M, Fasel N. Cell Death Discov 2 16024 (2016)
  50. Structural mechanism of allosteric activation of TRPML1 by PI(3,5)P2 and rapamycin. Gan N, Han Y, Zeng W, Wang Y, Xue J, Jiang Y. Proc Natl Acad Sci U S A 119 e2120404119 (2022)
  51. Direct imaging of the recruitment and phosphorylation of S6K1 in the mTORC1 pathway in living cells. Ahmed AR, Owens RJ, Stubbs CD, Parker AW, Hitchman R, Yadav RB, Dumoux M, Hawes C, Botchway SW. Sci Rep 9 3408 (2019)
  52. Multilayered regulation of TORC1-body formation in budding yeast. Sullivan A, Wallace RL, Wellington R, Luo X, Capaldi AP. Mol Biol Cell 30 400-410 (2019)
  53. Structural basis of allosteric regulation of Tel1/ATM kinase. Xin J, Xu Z, Wang X, Tian Y, Zhang Z, Cai G. Cell Res 29 655-665 (2019)
  54. Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo. Gramatica A, Schwarzer R, Brantley W, Varco-Merth B, Sperber HS, Hull PA, Montano M, Migueles SA, Rosenthal D, Hogan LE, Johnson JR, Packard TA, Grimmett ZW, Herzig E, Besnard E, Nekorchuk M, Hsiao F, Deeks SG, Snape M, Kiernan B, Roan NR, Lifson JD, Estes JD, Picker LJ, Verdin E, Krogan NJ, Henrich TJ, Connors M, Ott M, Pillai SK, Okoye AA, Greene WC. J Virol 95 JVI.02393-20 (2021)
  55. Functional Characterization of Target of Rapamycin Signaling in Verticillium dahliae. Li L, Zhu T, Song Y, Luo X, Feng L, Zhuo F, Li F, Ren M. Front Microbiol 10 501 (2019)
  56. Adaptations to chronic rapamycin in mice. Dodds SG, Livi CB, Parihar M, Hsu HK, Benavides AD, Morris J, Javors M, Strong R, Christy B, Hasty P, Sharp ZD. Pathobiol Aging Age Relat Dis 6 31688 (2016)
  57. Regulation of human mTOR complexes by DEPTOR. Wälchli M, Berneiser K, Mangia F, Imseng S, Craigie LM, Stuttfeld E, Hall MN, Maier T. Elife 10 e70871 (2021)
  58. Feedback regulation of TORC1 by its downstream effectors Npr1 and Par32. Varlakhanova NV, Tornabene BA, Ford MGJ. Mol Biol Cell 29 2751-2765 (2018)
  59. Interactions between mTORC2 core subunits Rictor and mSin1 dictate selective and context-dependent phosphorylation of substrate kinases SGK1 and Akt. Yu Z, Chen J, Takagi E, Wang F, Saha B, Liu X, Joubert LM, Gleason CE, Jin M, Li C, Nowotny C, Agard D, Cheng Y, Pearce D. J Biol Chem 298 102288 (2022)
  60. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma. Kondo S, Hirakawa H, Ikegami T, Uehara T, Agena S, Uezato J, Kinjyo H, Kise N, Yamashita Y, Tanaka K, Hasegawa N, Kiyuna A, Maeda H, Suzuki M, Gahana A. BMC Cancer 21 87 (2021)
  61. Redesigning TOR Kinase to Explore the Structural Basis for TORC1 and TORC2 Assembly. Hill A, Niles B, Cuyegkeng A, Powers T. Biomolecules 8 E36 (2018)
  62. capCLIP: a new tool to probe translational control in human cells through capture and identification of the eIF4E-mRNA interactome. Jensen KB, Dredge BK, Toubia J, Jin X, Iadevaia V, Goodall GJ, Proud CG. Nucleic Acids Res 49 e105 (2021)
  63. Dissecting the biology of mTORC1 beyond rapamycin. Yang G, Francis D, Krycer JR, Larance M, Zhang Z, Novotny CJ, Diaz-Vegas A, Shokat KM, James DE. Sci Signal 14 eabe0161 (2021)
  64. T-cell-specific mTOR deletion in mice ameliorated CD4+ T-cell survival in lethal sepsis induced by severe invasive candidiasis. Wang H, Bai G, Cui N, Han W, Long Y. Virulence 10 892-901 (2019)
  65. Target of rapamycin signaling is tightly and differently regulated in the plant response under distinct abiotic stresses. Pereyra CM, Aznar NR, Rodriguez MS, Salerno GL, Martínez-Noël GMA. Planta 251 21 (2019)
  66. Loss of miR-34 in Drosophila dysregulates protein translation and protein turnover in the aging brain. Srinivasan AR, Tran TT, Bonini NM. Aging Cell 21 e13559 (2022)
  67. Target of rapamycin controls hyphal growth and pathogenicity through FoTIP4 in Fusarium oxysporum. Li L, Zhu T, Song Y, Luo X, Datla R, Ren M. Mol Plant Pathol 22 1239-1255 (2021)
  68. Brassinosteroids modulate autophagy through phosphorylation of RAPTOR1B by the GSK3-like kinase BIN2 in Arabidopsis. Liao CY, Pu Y, Nolan TM, Montes C, Guo H, Walley JW, Yin Y, Bassham DC. Autophagy 19 1293-1310 (2023)
  69. The Ccr4-Not complex regulates TORC1 signaling and mitochondrial metabolism by promoting vacuole V-ATPase activity. Chen H, Miller PW, Johnson DL, Laribee RN. PLoS Genet 16 e1009046 (2020)
  70. CELL SIGNALING. Seeing mTORC1 specificity. Buel GR, Blenis J. Science 351 25-26 (2016)
  71. Functional and structural analyses of novel Smith-Kingsmore Syndrome-Associated MTOR variants reveal potential new mechanisms and predictors of pathogenicity. Besterman AD, Althoff T, Elfferich P, Gutierrez-Mejia I, Sadik J, Bernstein JA, van Ierland Y, Kattentidt-Mouravieva AA, Nellist M, Abramson J, Martinez-Agosto JA. PLoS Genet 17 e1009651 (2021)
  72. PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling. Yang W, Yang LF, Song ZQ, Shah SZA, Shah SZA, Cui YY, Li CS, Zhao HF, Gao HL, Zhou XM, Zhao DM. CNS Neurosci Ther 23 416-427 (2017)
  73. Signal integration in the (m)TORC1 growth pathway. Ramlaul K, Aylett CHS. Front Biol (Beijing) 13 237-262 (2018)
  74. Tracking the Activity of mTORC1 in Living Cells Using Genetically Encoded FRET-based Biosensor TORCAR. Zhou X, Li S, Zhang J. Curr Protoc Chem Biol 8 225-233 (2016)
  75. Directly imaging the localisation and photosensitization properties of the pan-mTOR inhibitor, AZD2014, in living cancer cells. Ahmed AR, Candeo A, D'Abrantes S, Needham SR, Yadav RB, Botchway SW, Parker AW. J Photochem Photobiol B 213 112055 (2020)
  76. Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cells. Li J, Wang X, Ma C, Xu S, Xu M, Yang J, Wang R, Xue L. Mol Med Rep 23 301 (2021)
  77. Identification of defined structural elements within TOR2 kinase required for TOR complex 2 assembly and function in Saccharomyces cerevisiae. Tsverov J, Yegorov K, Powers T. Mol Biol Cell 33 ar44 (2022)
  78. Rapamycin-ameliorated diabetic symptoms involved in increasing adiponectin expression in diabetic mice on a high-fat diet. Gong FH, Ye YN, Li JM, Zhao HY, Li XK. Kaohsiung J Med Sci 33 321-326 (2017)
  79. Chaiqi decoction ameliorates vascular endothelial injury in metabolic syndrome by upregulating autophagy. Chen X, Yan XR, Liu J, Zhang LP. Am J Transl Res 12 4902-4922 (2020)
  80. Deciphering the function and evolution of the target of rapamycin signaling pathway in microalgae. Mallén-Ponce MJ, Pérez-Pérez ME, Crespo JL. J Exp Bot 73 6993-7005 (2022)
  81. EGOC inhibits TOROID polymerization by structurally activating TORC1. Prouteau M, Bourgoint C, Felix J, Bonadei L, Sadian Y, Gabus C, Savvides SN, Gutsche I, Desfosses A, Loewith R. Nat Struct Mol Biol 30 273-285 (2023)
  82. Insights into Rad3 kinase recruitment from the crystal structure of the DNA damage checkpoint protein Rad26. Andersen KR. J Biol Chem 292 8149-8157 (2017)
  83. Stress- and metabolic responses of Candida albicans require Tor1 kinase N-terminal HEAT repeats. Qi W, Acosta-Zaldivar M, Flanagan PR, Liu NN, Jani N, Fierro JF, Andrés MT, Moran GP, Köhler JR. PLoS Pathog 18 e1010089 (2022)
  84. mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching. Shin S, Han MJ, Jedrychowski MP, Zhang Z, Shokat KM, Plas DR, Dephoure N, Yoon SO. Cell Rep 42 112868 (2023)
  85. A central role for a region in the middle. Stuttfeld E, Imseng S, Maier T. Elife 6 e25700 (2017)
  86. Cloning, expression, purification, and characterisation of the HEAT-repeat domain of TOR from the thermophilic eukaryote Chaetomium thermophilum. Robinson GC, Vegunta Y, Gabus C, Gaubitz C, Thore S. Protein Expr Purif 133 90-95 (2017)
  87. RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding. Lin Y, Wu Y, Zhang Q, Tu X, Chen S, Pan J, Xu N, Lin M, She P, Niu G, Chen Y, Li H. J Exp Clin Cancer Res 43 1 (2024)
  88. Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1. Layoun A, Goldberg AA, Baig A, Eng M, Attias O, Nelson K, Carella A, Amberber N, Fielhaber JA, Joung KB, Schmeing TM, Han Y, Downey J, Divangahi M, Roux PP, Kristof AS. Sci Rep 9 17620 (2019)
  89. Toward a Molecular Definition of Leucine-Dependent mTORC1 Activation. Abraham RT. Cell Metab 23 397-398 (2016)
  90. An affinity tool for the isolation of endogenous active mTORC1 from various cellular sources. Ibrahim YH, Pantelios S, Mutvei AP. J Biol Chem 299 104644 (2023)
  91. An expanded clinical spectrum of hypoinsulinaemic hypoketotic hypoglycaemia. Welters A, Leiter SM, Bachmann N, Bergmann C, Hoermann H, Korsch E, Meissner T, Payne F, Williams R, Hussain K, Semple RK, Kummer S. Orphanet J Rare Dis 18 360 (2023)
  92. Combining DNA scaffolds and acoustic force spectroscopy to characterize individual protein bonds. Wang YJ, Valotteau C, Aimard A, Villanueva L, Kostrz D, Follenfant M, Strick T, Chames P, Rico F, Gosse C, Limozin L. Biophys J 122 2518-2530 (2023)
  93. Excess Heritability Contribution of Alcohol Consumption Variants in the "Missing Heritability" of Type 2 Diabetes Mellitus. Ma Y, Zhou Z, Li X, Yan Z, Ding K, Chen D. Int J Mol Sci 22 12318 (2021)
  94. Exploratory Analysis of Selected Components of the mTOR Pathway Reveals Potentially Crucial Associations with Childhood Malnutrition. Palit P, Gazi MA, Das S, Hasan MM, Noor Z, Ferdous J, Alam MA, Nuzhat S, Islam MR, Mahfuz M, Haque R, Ahmed T. Nutrients 14 1612 (2022)
  95. PP2A inhibitor SET promotes mTORC1 and Bmi1 signaling through Akt activation and maintains the colony-formation ability of cancer cells. Kohyanagi N, Kitamura N, Ikeda S, Shibutani S, Sato K, Ohama T. J Biol Chem 300 105584 (2024)
  96. Raptor hunted by caspases. Martin R, Thome M, Martinon F, Fasel N. Cell Death Dis 7 e2242 (2016)
  97. TORC1 is an essential regulator of nutrient-controlled proliferation and differentiation in Leishmania. Myburgh E, Geoghegan V, Alves-Ferreira EV, Nievas YR, Grewal JS, Brown E, McLuskey K, Mottram JC. EMBO Rep 25 1075-1105 (2024)
  98. The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization. Liu Y, Zhang M, Jang H, Nussinov R. Chem Sci 15 1003-1017 (2024)
  99. Unmasking the True Identity of Rapamycin's Minor Conformer. Crull EB, Jain AN, Hawkins PCD, Cleves AE, Graziani EI, Williamson RT. J Nat Prod 86 1862-1869 (2023)
  100. mTOR Regulation of N-Myc Downstream Regulated 1 (NDRG1) Phosphorylation in Clear Cell Renal Cell Carcinoma. Valluri A, Wellman J, McCallister CL, Brown KC, Lawrence L, Russell R, Jensen J, Denvir J, Valentovic MA, Denning KL, Salisbury TB. Int J Mol Sci 24 9364 (2023)


Quick links